Two Sigma Investments’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-146,189
| Closed | -$3.45M | – | 3391 |
|
|
2023
Q4 | $3.45M | Sell |
146,189
-100
| -0.1% | -$2.36K | 0.01% | 1128 |
|
|
2023
Q3 | $2.18M | Sell |
146,289
-729,599
| -83% | -$10.9M | 0.01% | 1260 |
|
|
2023
Q2 | $9.59M | Sell |
875,888
-543,652
| -38% | -$5.95M | 0.02% | 616 |
|
|
2023
Q1 | $12.4M | Buy |
1,419,540
+1,030,443
| +265% | +$8.99M | 0.04% | 487 |
|
|
2022
Q4 | $2.44M | Buy |
389,097
+89,350
| +30% | +$560K | 0.01% | 1166 |
|
|
2022
Q3 | $1.05M | Buy |
299,747
+186,837
| +165% | +$654K | ﹤0.01% | 1400 |
|
|
2022
Q2 | $333K | Buy |
112,910
+27,496
| +32% | +$81.1K | ﹤0.01% | 1925 |
|
|
2022
Q1 | $266K | Buy |
85,414
+57,314
| +204% | +$178K | ﹤0.01% | 2212 |
|
|
2021
Q4 | $95K | Buy |
+28,100
| New | +$95K | ﹤0.01% | 2406 |
|
|
2021
Q3 | – | Sell |
-271,216
| Closed | -$1.18M | – | 3115 |
|
|
2021
Q2 | $1.18M | Sell |
271,216
-756,020
| -74% | -$3.3M | ﹤0.01% | 1607 |
|
|
2021
Q1 | $4.66M | Sell |
1,027,236
-88,241
| -8% | -$401K | 0.01% | 863 |
|
|
2020
Q4 | $6.4M | Buy |
1,115,477
+870,584
| +355% | +$5M | 0.02% | 643 |
|
|
2020
Q3 | $1.77M | Sell |
244,893
-63,376
| -21% | -$459K | 0.01% | 955 |
|
|
2020
Q2 | $1.08M | Sell |
308,269
-13,794
| -4% | -$48.1K | 0.01% | 1129 |
|
|
2020
Q1 | $477K | Sell |
322,063
-66,245
| -17% | -$98.1K | ﹤0.01% | 1265 |
|
|
2019
Q4 | $761K | Buy |
388,308
+359,608
| +1,253% | +$705K | ﹤0.01% | 1532 |
|
|
2019
Q3 | $147K | Buy |
+28,700
| New | +$147K | ﹤0.01% | 1792 |
|